Simvastatin and Rifaximin in Decompensated Cirrhosis
This randomized trial assesses the effect of 12 months of treatment with simvastatin plus rifaximin on acute-on-chronic liver failure incidence in patients with decompensated liver cirrhosis.
This randomized trial assesses the effect of 12 months of treatment with simvastatin plus rifaximin on acute-on-chronic liver failure incidence in patients with decompensated liver cirrhosis.
